Please assess the completion status of the following clinical trial:

Trial Title: Safety and Long-term Evaluation (up to 5 Years) of First Booster Immunization With Novartis' TBE Vaccine for Adults in Adolescents and Adults

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* healthy subjects who have completed study V48P7~Exclusion Criteria:~* acute illness at day of immunization~* general decrease in resistance~* progressive neurological disorders~* history of febrile or afebrile convulsions~* major congenital defects~* serious chronic illness~* hypersensitivity to study vaccine~* treatment with immunosuppressants or systemic corticosteroids, immunoglobulins, whole blood or plasma derivates

- Gender: ALL
- Minimum Age: 15 Years
- Maximum Age: 68 Years
- Healthy Volunteers: t

Study Arms:
- Arm 1 (Type: ACTIVE_COMPARATOR): Blood draw only, no vaccine
- Arm 2 (Type: ACTIVE_COMPARATOR): Blood draw only, no vaccine
- Arm 3 (Type: ACTIVE_COMPARATOR): Blood draw only, no vaccine
- Arm 4 (Type: ACTIVE_COMPARATOR): Blood draw only, no vaccine

Based on this trial design, predict the completion outcome and termination type (if applicable).